No, Wellbutrin (bupropion) is NOT used for malaria prophylaxis
Bupropion has no role whatsoever in malaria prevention or treatment. This is an antidepressant medication with no antimalarial activity.
Why This Confusion May Arise
The name similarity between "Wellbutrin" and "Malarone" (atovaquone-proguanil, an actual antimalarial) or confusion with other drug names may lead to this question. However, these are completely different medications with entirely different mechanisms and indications.
What Wellbutrin Actually Does
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) approved exclusively for 1:
- Major depressive disorder
- Smoking cessation (as Zyban brand)
- Seasonal affective disorder
The FDA labeling contains no mention of malaria, parasitic infections, or any antimicrobial properties 1.
Actual Malaria Prophylaxis Options
For travelers requiring malaria chemoprophylaxis, the established options based on resistance patterns are 2:
For chloroquine-sensitive areas:
- Chloroquine 300 mg base weekly
For chloroquine-resistant P. falciparum areas:
- First-line: Mefloquine 250 mg weekly
- Alternatives: Doxycycline 100 mg daily, or atovaquone-proguanil
For P. vivax/ovale (preventing relapses):
- Primaquine after leaving endemic area (requires G6PD testing)
More recent guidelines also support atovaquone-proguanil and artemisinin-based combinations 3.
Critical Safety Point
Using bupropion instead of appropriate antimalarial prophylaxis would leave a traveler completely unprotected against malaria, a potentially fatal disease. This represents a dangerous medication error that could result in severe illness or death from preventable malaria infection.
If someone is traveling to a malarious area, they need proper antimalarial chemoprophylaxis as outlined above—never bupropion.